Ming‐Sun Yu

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer

J.S. Chen, Chih‐Hung Hsu, Nai‐Jung Chiang et al. · Annals of Oncology · 2015 · 157 citations

Gastrointestinal Oncology, Medicine, Biliary Cancer +7

β2-AR signaling controls trastuzumab resistance-dependent pathway

Daifang Liu, Zhengyan Yang, Tianxun Wang et al. · Oncogene · 2015 · 84 citations

Signal Transduction, Signaling Pathway, Receptor Tyrosine Kinase +4

Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan

Wen-Chi Shen, Jen‐Shi Chen, Yu‐Yun Shao et al. · Journal of Pain and Symptom Management · 2017 · 43 citations · Full text

Pain Therapy, Pain Research, Health Sciences +12

Prognostic Value of Platelet Count in Diffuse Large B-Cell Lymphoma

Ling-Ping Chen, Shyh‐Jer Lin, Ming‐Sun Yu · Clinical Lymphoma Myeloma & Leukemia · 2011 · 39 citations

Thrombopoiesis, Lymphoid Neoplasia, Hematological Malignancy +6

Enhanced Cytotoxicity of Natural Killer Cells following the Acquisition of Chimeric Antigen Receptors through Trogocytosis

Fu-Nan Cho, Tsung-Hsien Chang, Chih‐Wen Shu et al. · PLoS ONE · 2014 · 39 citations · Full text

Cell Therapy, Immunology, Nk Cells +17